Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis
Journal article published in 2019 by
Francesca Palandri 
,
Massimo Breccia ,
Massimiliano Bonifacio,
Nicola Polverelli,
Elena M. Elli,
Giulia Benevolo ,
Mario Tiribelli ,
Elisabetta Abruzzese ,
Alessandra Iurlo,
Florian H. Heidel,
Micaela Bergamaschi,
Alessia Tieghi,
Monica Crugnola,
Francesco Cavazzini,
Gianni Binotto
and other authors.
,
Massimo Breccia ,
Massimiliano Bonifacio,
Nicola Polverelli,
Elena M. Elli,
Giulia Benevolo ,
Mario Tiribelli ,
Elisabetta Abruzzese ,
Alessandra Iurlo,
Florian H. Heidel,
Micaela Bergamaschi,
Alessia Tieghi,
Monica Crugnola,
Francesco Cavazzini,
Gianni Binotto
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 